Streamex Corp. PE Ratio
The price-to-earnings (P/E) ratio tells you how many dollars investors pay for each dollar of a company's annual profit. It is market capitalization divided by net income over the trailing four quarters, meaning the four most recent filed quarters added together, and the table shows both amounts. A higher P/E means investors are paying more for each dollar of current earnings, often because they expect profits to grow; a negative P/E means the company lost money over those four quarters. Each point uses the filed share count and the last closing price on or before that quarter-end date, never today's price.
- Streamex Corp. pe ratio for the quarter ending 2026-06-30 was -0.19, a change of 8.2 year-over-year.
- Streamex Corp. pe ratio for the quarter ending 2026-03-31 was -0.22, a change of 1.28 year-over-year.
- Streamex Corp. pe ratio for the quarter ending 2025-12-31 was -0.33, a change of 2.16 year-over-year.
- Streamex Corp. pe ratio for the quarter ending 2025-09-30 was -5.11, a change of -4.74 year-over-year.
- Streamex Corp. pe ratio for fiscal 2026 was -0.19.
- Streamex Corp. pe ratio for fiscal 2025 was -0.33, a change of 2.16 from fiscal 2024.
- Streamex Corp. pe ratio for fiscal 2024 was -2.49, a change of -1.01 from fiscal 2023.
- Streamex Corp. pe ratio for fiscal 2023 was -1.48, a change of -0.62 from fiscal 2022.
- Available history
- 2014-12-31 to 2026-06-30
- Data captured
Historical PE Ratio
Annual PE Ratio
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| IRIDEX CORP (IRIX) | United States | $0.011B | |
| ENDRA Life Sciences Inc. (NDRA) | United States | $0.009B |